Submissions from 2024
The Chemistry of Phytoplankton, Xiaoying Liu, Zhiwei Bian, Shian Hu, Cody F Dickinson, Menny M Benjamin, Jia Jia, Yintai Tian, Allen Place, George S Hanna, Hendrik Luesch, Peter Croot, Maggie M Reddy, Olivier P Thomas, Gary Hardiman, Melany P Puglisi, Ming Yang, Zhi Zhong, John J Lemasters, Jeffrey E Korte, Amanda L Waters, Carl E Heltzel, R Thomas Williamson, Wendy K Strangman, Frederick A. Valeriote, Marcus A Tius, Giacomo R DiTullio, Daneel Ferreira, Alexander Alekseyenko, Shengpeng Wang, Mark T Hamann, and Xiaojuan Wang
Neoantigens and cancer-testis antigens as promising vaccine candidates for triple-negative breast cancer: Delivery strategies and clinical trials, RamaRao Malla, Mundla Srilatha, Veda Muppala, Batoul Farran, Virander Singh Chauhan, and Ganji Purnachandra Nagaraju
Weakly supervised large-scale pancreatic cancer detection using multi-instance learning, Shyamapada Mandal, Keerthiveena Balraj, Hariprasad Kodamana, Chetan Arora, Julie M. Clark, David S. Kwon, and Anurag S. Rathore
MK591 (Quiflapon), a 5-lipoxygenase inhibitor, kills pancreatic cancer cells via downregulation of protein kinase C-epsilon, Jitender Monga, Ritisha Ghosh, Rohith K. Guddeti, Dhananjay A. Chitale, Gazala Khan, and Jagadananda Ghosh
Tumor-Associated Carbohydrate Antigen 19-9 (CA 19-9), a Promising Target for Antibody-Based Detection, Diagnosis, and Immunotherapy of Cancer, Athar Nakisa, Lorenzo F. Sempere, Xi Chen, Linda T. Qu, Daniel Woldring, Howard C. Crawford, and Xuefei Huang
Uptake of Lung Cancer Screening CT After a Provider Order for Screening in the PROSPR-Lung Consortium, Christine Neslund-Dudas, Amy Tang, Elizabeth Alleman, Katherine Zarins, Pin Li, Michael Simoff, Jennifer Elston Lafata, Katharine A. Rendle, Andrea Burnett Hartman, Stacey A. Honda, Caryn Oshiro, Oluwatosin Olaiya, Robert T. Greenlee, Anil Vachani, and Debra P. Ritzwoller
Selective Personalized RadioImmunotherapy for Locally Advanced Non-Small-Cell Lung Cancer Trial (SPRINT), Nitin Ohri, Shruti Jolly, Benjamin T. Cooper, Rafi Kabarriti, William R. Bodner, Jonathan Klein, Chandan Guha, Shankar Viswanathan, Elaine Shum, Joshua K. Sabari, Haiying Cheng, Rasim A. Gucalp, Enrico Castellucci, Angel Qin, Shirish M. Gadgeel, and Balazs Halmos
Repeat Next-Generation Sequencing Testing on Progression in Men With Metastatic Prostate Cancer Can Identify New Actionable Alterations, Joseph J. Park, Alec Chu, Jinju Li, Alicia Ali, Rana R. McKay, Clara Hwang, Matthew K. Labriola, Albert Jang, Deepak Kilari, George Mo, Deepak Ravindranathan, Laura S. Graham, Alexandra Sokolova, Abhishek Tripathi, Amanda Pilling, Tanya Jindal, Aditya Ravindra, Frank C. Cackowski, Patrick L. Sweeney, Bicky Thapa, Taylor S. Amery, Elisabeth I. Heath, Rohan Garje, Yousef Zakharia, Vadim S. Koshkin, Mehmet A. Bilen, Michael T. Schweizer, Pedro C. Barata, Tanya B. Dorff, Marcin Cieslik, Ajjai S. Alva, and Andrew J. Armstrong
Phase 1/2 study of monalizumab plus durvalumab in patients with advanced solid tumors, Sandip P. Patel, Teresa Alonso-Gordoa, Susana Banerjee, Ding Wang, Jarushka Naidoo, Nathan E. Standifer, Doug C. Palmer, Lin-Yang Cheng, Panagiotis Kourtesis, Maria L. Ascierto, Mayukh Das, Jennifer R. Diamond, Matthew D. Hellmann, and Benedito A. Carneiro
Entrectinib in ROS1-positive advanced non-small cell lung cancer: the phase 2/3 BFAST trial, Solange Peters, Shirish M. Gadgeel, Tony Mok, Ernest Nadal, Saadettin Kilickap, Aurélie Swalduz, Jacques Cadranel, Shunichi Sugawara, Chao-Hua Chiu, Chong-Jen Yu, Mor Moskovitz, Tomohiro Tanaka, Rhea Nersesian, Sarah M. Shagan, Margaret Maclennan, Michael Mathisen, Vijay Bhagawati-Prasad, Cheick Diarra, Zoe June Assaf, Venice Archer, and Rafal Dziadziuszko
Devimistat (CPI-613) With Modified Fluorouarcil, Oxaliplatin, Irinotecan, and Leucovorin (FFX) Versus FFX for Patients With Metastatic Adenocarcinoma of the Pancreas: The Phase III AVENGER 500 Study, Philip A. Philip, Vaibhav Sahai, Nathan Bahary, Amit Mahipal, Anup Kasi, Caio Max S Rocha Lima, Angela T. Alistar, Paul E. Oberstein, Talia Golan, Jean-Philippe Metges, Jill Lacy, Christos Fountzilas, Charles D. Lopez, Michel Ducreux, Pascal Hammel, Mohamed Salem, David Bajor, Al B. Benson, Sanjeev Luther, Timothy Pardee, and Eric Van Cutsem
CD19-directed CART therapy for T-cell/histiocyte-rich large B-cell lymphoma, Priyanka A. Pophali, Joshua A. Fein, Kwang W. Ahn, Molly Allbee-Johnson, Nausheen Ahmed, Farrukh T. Awan, Shatha Farhan, Natalie S. Grover, Talal Hilal, Madiha Iqbal, Joseph Maakaron, Dipenkumar Modi, Elham Nasrollahi, Levanto G. Schachter, Craig Sauter, Mehdi Hamadani, Alex Herrera, Roni Shouval, and Mazyar Shadman
Increased Fatigability and Impaired Skeletal Muscle Microvascular Reactivity in Adults with Obstructive Sleep Apnea: A Cross-Sectional Study, Shipra Puri, Monira Aldhahi, Lisa M K Chin, Andrew A Guccione, Vivek Jain, and Jeffrey E Herrick
A Phase II Trial of Pevonedistat and Docetaxel in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer, Angel Qin, Leah Wells, Binu Malhotra, Shirish M. Gadgeel, Bryan J. Schneider, Nithya Ramnath, John D. Rice, and Gregory P. Kalemkerian
EVERYTHING YOU NEED TO KNOW ABOUT MENTORING TO ACHIEVE YOUR CAREER GOALS: A COMPREHENSIVE MENTORSHIP WORKBOOK, Dionisia Quiroga, Fawzi Abu Rous, Rajat Thawani, Dawood Findakly, Fionnuala Crowley, Anusha Chidharla, and Muhammad Salman Faisal
Observational cohort study of long-term outcomes of liver transplantation in haemophilia, Margaret V. Ragni, Jessica Callis, Nabil Daoud, Brian Hu, Matthew Manuel, Jarren Santos, Jonathan Schwartz, Kenneth D. Friedman, Peter Kouides, Philip Kuriakose, Andrew D. Leavitt, Ming Y. Lim, Nicoletta Machin, Michael Recht, and Tammuella Chrisentery-Singleton
Evaluating soluble Axl as a biomarker for glioblastoma: A pilot study, Daniel Raymond, Melanie Fukui, Samuel Zwernik, Amin Kassam, Richard Rovin, and Parvez Akhtar
Rates of Downstream Procedures and Complications Associated With Lung Cancer Screening in Routine Clinical Practice : A Retrospective Cohort Study, Katharine A. Rendle, Chelsea A. Saia, Anil Vachani, Andrea N. Burnett-Hartman, V. Paul Doria-Rose, Sarah Beucker, Christine Neslund-Dudas, Caryn Oshiro, Roger Y. Kim, Jennifer Elston-Lafata, Stacey A. Honda, Debra Ritzwoller, Jocelyn V. Wainwright, Nandita Mitra, and Robert T. Greenlee
Patterns of B-cell lymphocyte expression changes in pre- and post-malignant prostate tissue are associated with prostate cancer progression, Sudha M. Sadasivan, Ian M. Loveless, Yalei Chen, Nilesh S. Gupta, Ryan Sanii, Kevin R. Bobbit, Dhananjay A. Chitale, Sean R. Williamson, Andrew G. Rundle, and Benjamin A. Rybicki
Tuft cells transdifferentiate to neural-like progenitor cells in the progression of pancreatic cancer, Daniel J. Salas-Escabillas, Megan T. Hoffman, Sydney M. Brender, Jacee S. Moore, Hui-Ju Wen, Simone Benitz, Erick T. Davis, Daniel Long, Allison Wombwell, Ella Rose D. Chianis, Brittany L. Allen-Petersen, Nina G. Steele, Rosalie C. Sears, Ichiro Matsumoto, Kathleen E. DelGiorno, and Howard C. Crawford
At the Speed of SOUND: The Pace of Change for Axillary Management in Breast Cancer, Theresa Schwartz
Axillary nodal staging in breast cancer: what have we learned?, Theresa L. Schwartz
A Retrospective Study of Fertility Counseling and Preservation Rates for Women of Reproductive Age With Breast Care After Integrating a Fertility Specialist Into a Multidisciplinary Tumor Board, Monique Swain, Madison Miller, Cara Cannella, Samfee Doe, Lindsay Petersen, and Jessica Bensenhaver
Differences in Patient-Reported Outcome Measures in Patients With Cancer Six Months Before Death, Samantha Tam, Nada Al-Antary, Eric Adjei Boakye, Kylie Springer, Laila M. Poisson, Wan-Ting Su, Jeewanjot S. Grewal, Theresa Zatirka, Michael Ryan, Benjamin Movsas, and Steven S. Chang
BUB1 Inhibition Overcomes Radio- and Chemoradiation Resistance in Lung Cancer, Shivani Thoidingjam, Sushmitha Sriramulu, Oudai Hassan, Stephen L. Brown, Farzan Siddiqui, Benjamin Movsas, Shirish M. Gadgeel, and Shyam Nyati
Deciphering cellular plasticity in pancreatic cancer for effective treatments, Md Hafiz Uddin, Dingqiang Zhang, Irfana Muqbil, Bassel F. El-Rayes, Herbert Chen, Philip A. Philip, and Asfar S. Azmi
Targeting mitochondrial metabolism with CPI-613 in chemoresistant ovarian tumors, Mary P. Udumula, Faraz Rashid, Harshit Singh, Tim Pardee, Sanjeev Luther, Tanya Bhardwaj, Km Anjaly, Sofia Piloni, Miriana Hijaz, Radhika Gogoi, Philip A. Philip, Adnan R. Munkarah, Shailendra Giri, and Ramandeep Rattan
Intratumoral Cell Neighborhoods Coordinate Outcomes in Pancreatic Ductal Adenocarcinoma, Max M. Wattenberg, Sarah Colby, Ignacio Garrido-Laguna, Yuqing Xue, Renee Chang, Devora Delman, Jesse Lee, Kajsa Affolter, Sean J. Mulvihill, M. Shaalan Beg, Andrea Wang-Gillam, James Lloyd Wade, Katherine A. Guthrie, E. Gabriela Chiorean, Syed A. Ahmad, Andrew M. Lowy, Philip A. Philip, Davendra P. S Sohal, and Gregory L. Beatty
Expert and patient cognitive interviews in the development of a novel alcohol insight scale for use in hepatology and liver transplantation, Gerald S. Winder, Victoria Gill, Shivali Patel, Haila Asefa, and Jessica L. Mellinger
A next-generation BRAF inhibitor overcomes resistance to BRAF inhibition in patients with BRAF-mutant cancers using pharmacokinetics-informed dose escalation, Rona Yaeger, Meredith A. McKean, Rizwan Haq, J. Thaddeus Beck, Matthew H. Taylor, Jonathan Eliezer Cohen, Daniel W. Bowles, Shirish M. Gadgeel, Catalin Mihalcioiu, Kyriakos P. Papadopoulos, Eli L. Diamond, Keren B. Sturtz, Gang Feng, Stefanie K. Drescher, Micaela B. Reddy, Bhaswati Sengupta, Arnab K. Maity, Suzy A. Brown, Anurag Singh, Eric N. Brown, Brian R. Baer, Jim Wong, Tung-Chung Mou, Wen-I Wu, Dean R. Kahn, Sunyana Gadal, Neal Rosen, John J. Gaudino, Patrice A. Lee, Dylan P. Hartley, and S. Michael Rothenberg
Notch Signaling Regulates Immunosuppressive Tumor-Associated Macrophage Function in Pancreatic Cancer, Wei Yan, Rosa E. Menjivar, Monica E. Bonilla, Nina G. Steele, Samantha B. Kemp, Wenting Du, Katelyn L. Donahue, Kristee L. Brown, Eileen S. Carpenter, Faith R. Avritt, Valerie M. Irizarry-Negron, Sion Yang, William R. Burns, Yaqing Zhang, Marina Pasca di Magliano, and Filip Bednar
Clinical implications of AR alterations in advanced prostate cancer: a multi-institutional collaboration, Zeynep B. Zengin, Nicholas C. Henderson, Joseph J. Park, Alicia Ali, Charles Nguyen, Clara Hwang, Pedro C. Barata, Mehmet A. Bilen, Laura Graham, George Mo, Deepak Kilari, Abhishek Tripathi, Matthew Labriola, Shoshana Rothstein, Rohan Garje, Vadim S. Koshkin, Vaibhav G. Patel, Michael T. Schweizer, Andrew J. Armstrong, Rana R. McKay, Ajjai Alva, and Tanya Dorff
Altered histone acetylation patterns in pancreatic cancer cell lines induce subtype‑specific transcriptomic and phenotypical changes, Quan Zhou, Svenja Pichlmeier, Anna Maria Denz, Nicole Schreiner, Tobias Straub, Simone Benitz, Julia Wolff, Lisa Fahr, Maria Del Socorro Escobar Lopez, Jörg Kleeff, Julia Mayerle, Ujjwal Mukund Mahajan, and Ivonne Regel
Submissions from 2023
Outcomes of Patients with Thrombocytopenia Evaluated at Hematology Subspecialty Clinics, Zaid H. Abdel-Rahman, Kevin C. Miller, Hiba Jabbour, Yaser Alkhatib, and Vijayalakshmi Donthireddy
Brief Report: Prognostic Relevance of 3q Amplification in Squamous Cell Carcinoma of the Lung, Fawzi Abu Rous, Pin Li, Shannon Carskadon, Sunny R. K Singh, Rebecca Chacko, Hassan Abushukair, Shirish M. Gadgeel, and Nallasivam Palanisamy
Challenges Faced by J-1 International Medical Graduates (IMGs) During COVID-19 Pandemic, Fawzi Abu Rous and Ivy Riano
Clinicopathologic characteristics of early-onset breast cancer: a comparative analysis of cases from across Ghana, Patrick Kafui Akakpo, Emmanuel Gustav Imbeah, Lawrence Edusei, Simon Naporo, Kofi Ulzen-Appiah, Joe Nat Clegg-Lamptey, Florence Dedey, Josephine Nsaful, Nelson Affram, Beatrice Wiafe, Samuel Mensah, Michael Nortey, Mohammed Sheriff, Forster Amponsah-Manu, Kwabena Agbedinu, and Evelyn M. Jiagge
Phase II trial of nivolumab and metformin in patients with treatment-refractory microsatellite stable metastatic colorectal cancer, Mehmet Akce, Batoul Farran, Jeffrey M. Switchenko, Manali Rupji, Sandra Kang, Lana Khalil, Amanda Ruggieri-Joyce, Brian Olson, Walid L. Shaib, Christina Wu, Olatunji B. Alese, Maria Diab, Gregory B. Lesinski, and Bassel F. El-Rayes
A Rare Presentation of Concomitant Lung Disease and Hepatitis After Rituximab Treatment: A Case Report, Linda Albusoul, Hussna Abunafessa, and Vrushali Dabak
Lifestyle Modifications and Nutritional and Therapeutic Interventions in Delaying the Progression of Chronic Kidney Disease: A Review, Lean Alkhatib, Lorena A. Velez Diaz, Samyukta Varma, Arsh Chowdhary, Prachi Bapat, Hai Pan, Geetika Kukreja, Prasannalaxmi Palabindela, Sri Abirami Selvam, and Kartik Kalra
Clinical Outcome in Patients With Early-Stage Small Cell Lung Cancer Treated With Surgery or Radiation in the Absence of Prophylactic Cranial Irradiation: A Single-Center Retrospective Study, Sondos Al Khatib, Khaled Adil, Lonni Schultz, Shirish M. Gadgeel, Andrew Popoff, Munther Ajlouni, Michael Simoff, Benjamin Movsas, and Aharon Feldman
A Case of Immune-Mediated Pneumonitis Associated With Dual Nivolumab and Ipilimumab Immunotherapy Treatment, Tala Al-Saghir, Noor Suleiman, Benjamin D. Goodman, Michael W. Ferguson, and Sheela Tejwani
Persistent Peri-Ablation Blood-Brain Barrier Opening After Laser Interstitial Thermal Therapy for Brain Tumors., Seamus Bartlett, Tavarekere N. Nagaraja, Brent Griffith, Katelynn G. Farmer, Meredith Van Harn, Sameah A. Haider, Rachel J. Hunt, Glauber Cabral, Robert A. Knight, Olivia G. Valadie, Stephen L. Brown, James R. Ewing, and Ian Y. Lee
Phase I Study of Single-Agent Anti-Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates, Julie R. Brahmer, Charles G. Drake, Ira Wollner, John D. Powderly, Joel Picus, William H. Sharfman, Elizabeth Stankevich, Alice Pons, Theresa M. Salay, Tracee L. McMiller, Marta M. Gilson, Changyu Wang, Mark Selby, Janis M. Taube, Robert Anders, Lieping Chen, Alan J. Korman, Drew M. Pardoll, Israel Lowy, and Suzanne L. Topalian
Clinical implications of Wnt signaling alterations in patients (pts) with advanced prostate cancer (aPC), Amanda Broderick, Jinju Li, Alec Chu, Clara Hwang, Pedro C. Barata, Frank C. Cackowski, Matthew Labriola, Alyssa Ghose, Mehmet A. Bilen, Deepak Kilari, Laura Graham, Abhishek Tripathi, Rohan Garje, Vadim S. Koshkin, Elizabeth Pan, Tanya B. Dorff, Rana R. McKay, Michael T. Schweizer, Ajjai S. Alva, and Andrew J. Armstrong
A First-in-human, Dose-escalation Study of the Methionine Aminopeptidase 2 Inhibitor M8891 in Patients with Advanced Solid Tumors, Michael A. Carducci, Ding Wang, Christina Habermehl, Matthias Bödding, Felix Rohdich, Floriane Lignet, Klaus Duecker, Oleksandr Karpenko, Linda Pudelko, Claude Gimmi, and Patricia LoRusso
KRT17High/CXCL8+ tumor cells display both classical and basal features and regulate myeloid infiltration in the pancreatic cancer microenvironment, Eileen S Carpenter, Padma Kadiyala, Ahmed M Elhossiny, Samantha B Kemp, Jay Li, Nina G. Steele, Rémy Nicolle, Zeribe C Nwosu, Julia Freeman, Henry Dai, Daniel Paglia, Wenting Du, Katelyn Donahue, Jacqueline Morales, Paola I Medina-Cabrera, Monica E Bonilla, Lindsey Harris, Stephanie The, Valerie Gunchick, Nicole Peterson, Kristee Brown, Michael Mattea, Carlos E Espinoza, Jake McGue, Sarah M Kabala, Rachel K Baliira, Nur M Renollet, Ayden G Mooney, Jianhua Liu, Sean Bhalla, Jeremy P Farida, Christopher Ko, Jorge D Machicado, Richard S Kwon, Erik-Jan Wamsteker, Allison Schulman, Michelle A Anderson, Ryan Law, Anoop Prabhu, Pierre A Coulombe, Arvind Rao, Timothy L Frankel, Filip Bednar, Jiaqi Shi, Vaibhav Sahai, and Marina Pasca di Magliano
ALK-Positive Anaplastic Large Cell Lymphoma Associated With Hemophagocytic Lymphohistiocytosis, Shing Chao, Zaid I. Al-Saheli, Wei Zhao, Sharmila Ghosh, and Vrushali Dabak
Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and Cancer Consortium, Toni K. Choueiri, Chris Labaki, Ziad Bakouny, Chih-Yuan Hsu, Andrew L. Schmidt, Gilberto de Lima Lopes, Clara Hwang, Sunny R. K Singh, Chinmay Jani, Lisa B. Weissmann, Elizabeth A. Griffiths, Susan Halabi, Ulysses Wu, Stephanie Berg, Timothy E. O'Connor, Trisha M. Wise-Draper, Orestis A. Panagiotou, Elizabeth J. Klein, Monika Joshi, Fares Yared, Miriam Santos Dutra, Na Tosha N. Gatson, Sibel Blau, Harpreet Singh, Rahul Nanchal, Rana R. McKay, Taylor K. Nonato, Ryann Quinn, Samuel M. Rubinstein, Matthew Puc, Blanche H. Mavromatis, Praveen Vikas, Bryan Faller, Howard A. Zaren, Salvatore Del Prete, Karen Russell, Daniel Y. Reuben, Melissa K. Accordino, Harpreet Singh, Christopher R. Friese, Sanjay Mishra, Donna R. Rivera, Yu Shyr, Dimitrios Farmakiotis, and Jeremy L. Warner
Lorazepam Stimulates IL6 Production and Is Associated with Poor Survival Outcomes in Pancreatic Cancer, Abigail C. Cornwell, Arwen A. Tisdale, Swati Venkat, Kathryn E. Maraszek, Abdulrahman A. Alahmari, Anthony George, Kristopher Attwood, Madison George, Donald Rempinski, Janusz Franco-Barraza, Mukund Seshadri, Mark D. Parker, Eduardo Cortes Gomez, Christos Fountzilas, Edna Cukierman, Nina G. Steele, and Michael E. Feigin
Images in Immunotherapy and Precision Oncology: Angiosarcoma of the Spleen and Liver, Anagha Deshpande, Javier Munoz, Katalin Kelemen, Vrushali Dabak, Amr Hanbali, and Razelle Kurzrock
Clinical implications of AR alterations in advanced prostate cancer: A multi-institutional collaboration, Tanya Dorff, Zeynep Zengin, Nicholas Henderson, Alicia Ali, Charles Nguyen, Clara Hwang, Pedro C Barata, Mehmet Bilen, Laura Graham, George Mo, Deepak Kilari, Abhishek Tripathi, Matthew Labriola, Shoshana Rothstein, Rohan Garje, Vadim Koshkin, Vaibhav Patel, Michael Schweizer, Andrew Armstrong, Rana McKay, and Ajjai Alva
SHP2 Inhibition Sensitizes Diverse Oncogene-Addicted Solid Tumors to Re-treatment with Targeted Therapy, Alexander Drilon, Manish R. Sharma, Melissa L. Johnson, Timothy A. Yap, Shirish M. Gadgeel, Dale Nepert, Gang Feng, Micaela B. Reddy, Allison S. Harney, Mohamed Elsayed, Adam W. Cook, Christina E. Wong, Ronald J. Hinklin, Yutong Jiang, Eric N. Brown, Nickolas A. Neitzel, Ellen R. Laird, Wen-I Wu, Anurag Singh, Ping Wei, Keith A. Ching, John J. Gaudino, Patrice A. Lee, Dylan P. Hartley, and S. Michael Rothenberg
The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022, Michel Ducreux, Ghassan K. Abou-Alfa, Tanios S. Bekaii-Saab, Jordan D. Berlin, Andrés Cervantes, Thierry de Baere, Cathy Eng, Peter Galle, Sharlene Gill, Thomas Gruenberger, Karin Haustermans, Angela Lamarca, Pierre Laurent-Puig, Josep M. Llovet, Florian Lordick, Teresa Macarulla, Deborah Mukherji, Kei Muro, Radka Obermannova, Juan Manuel O'Connor, Eileen O'Reilly, Pia Österlund, Philip A. Philip, Gerald Prager, Erika Ruiz-Garcia, Bruno Sangro, Thomas Seufferlein, Josep Tabernero, Chris Verslype, Harpreet Wasan, and Eric Van Cutsem
Neuropsychiatric disorders in adults undergoing chimeric antigen receptor T cells therapy for aggressive lymphomas and acute lymphoblastic leukemia, Josephine Emole, Odunayo Lawal, Oleksandra Lupak, Hemalatha Rangarajan, and Itoro Udo
Graft-versus-host disease: teaching old drugs new tricks at less cost, Shatha Farhan and Shernan G. Holtan
Survival Outcomes in Women with Unilateral, Triple-Negative, Breast Cancer Correlated with Contralateral Prophylactic Mastectomy, Genevieve A. Fasano, Solange Bayard, Yalei Chen, Jennifer Marti, Rache Simmons, Alexander Swistel, Jessica Bensenhaver, Melissa Davis, and Lisa Newman
Examining differences in long-term weight loss outcomes after bariatric surgery: The role of romantic relationship status, Megan Ferber, Leah M. Hecht, Kellie M. Martens, Aaron Hamann, Arthur M. Carlin, and Lisa R. Miller-Matero
Phase II study of docetaxel and trametinib in patients with KRAS mutation positive recurrent non-small cell lung cancer (NSCLC) (SWOG S1507, NCT-02642042), Shirish M. Gadgeel, Jieling Miao, Jonathan W. Riess, James Moon, Philip C. Mack, Gregory J. Gerstner, Timothy F. Burns, Asma Taj, Wallace L. Akerley, Konstantin H. Dragnev, Noel Laudi, Mary W. Redman, Jhanelle E. Gray, David R. Gandara, and Karen Kelly
Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC, Marina C. Garassino, Shirish M. Gadgeel, Silvia Novello, Balazs Halmos, Enriqueta Felip, Giovanna Speranza, Rina Hui, Edward B. Garon, Hidehito Horinouchi, Shunichi Sugawara, Delvys Rodriguez-Abreu, Martin Reck, Razvan Cristescu, Deepti Aurora-Garg, Andrey Loboda, Jared Lunceford, Julie Kobie, Mark Ayers, Bilal Piperdi, M. Catherine Pietanza, and Luis Paz-Ares
Pembrolizumab Plus Pemetrexed and Platinum in Nonsquamous Non-Small-Cell Lung Cancer: 5-Year Outcomes From the Phase 3 KEYNOTE-189 Study, Marina C. Garassino, Shirish M. Gadgeel, Giovanna Speranza, Enriqueta Felip, Emilio Esteban, Manuel Dómine, Maximilian J. Hochmair, Steven F. Powell, Helge G. Bischoff, Nir Peled, Francesco Grossi, Ross R. Jennens, Martin Reck, Rina Hui, Edward B. Garon, Takayasu Kurata, Jhanelle E. Gray, Paul Schwarzenberger, Erin Jensen, M. Catherine Pietanza, and Delvys Rodríguez-Abreu
A Case of Right Ventricular Failure Secondary to Acute Chest Syndrome Managed With Early Red Cell Exchange Transfusion, Abeselom Geletu, Josephine Emole, Alaa Abu Sayf, Oscar A. Hinojosa, and Alexandra Gastesi
Carcinoma En Cuirasse: A Rare but Striking Cutaneous Manifestation of Metastatic Breast Cancer, Manasi Godbole, Kashmira Wani, Shereen Q. Zia, and Vrushali Dabak
Sepsis-related outcomes of patients with Philadelphia-negative myeloproliferative neoplasms, Luis F. Gonzalez Mosquera, Bernard Moscoso, Pool Tobar, Diana Cardenas-Maldonado, Alida I. Podrumar, Ruben Mesa, and John A. Cuenca
Sepsis-Related Outcomes of Patients with Philadelphia-Negative Myeloproliferative Neoplasms, Luis F. Gonzalez Mosquera, Bernard Moscoso, Pool Tobar, Diana Cardenas-Maldonado, Alida I. Podrumar, Ruben Mesa, and John A. Cuenca
Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19, Shuchi Gulati, Chih-Yuan Hsu, Surbhi Shah, Pankil K Shah, Rebecca Zon, Susan Alsamarai, Joy Awosika, Ziad El-Bakouny, Babar Bashir, Alicia Beeghly, Stephanie Berg, Daniel de-la-Rosa-Martinez, Deborah B. Doroshow, Pamela C. Egan, Joshua Fein, Daniel B. Flora, Christopher R. Friese, Ariel Fromowitz, Elizabeth A. Griffiths, Clara Hwang, Chinmay Jani, Monika Joshi, Hina Khan, Elizabeth J. Klein, Natalie Knox Heater, Vadim S. Koshkin, Daniel H. Kwon, Chris Labaki, Tahir Latif, Rana R. McKay, Gayathri Nagaraj, Elizabeth S. Nakasone, Taylor Nonato, Hyma V. Polimera, Matthew Puc, Pedram Razavi, Erika Ruiz-Garcia, Renee Maria Saliby, Aditi Shastri, Sunny R. K Singh, Vicky Tagalakis, Diana Vilar-Compte, Lisa B. Weissmann, Cy R. Wilkins, Trisha M. Wise-Draper, Michael T. Wotman, James J. Yoon, Sanjay Mishra, Petros Grivas, Yu Shyr, Jeremy L. Warner, Jean M. Connors, Dimpy P. Shah, and Rachel P. Rosovsky
MRTX-500 Phase 2 Trial: Sitravatinib With Nivolumab in Patients With Non-Squamous Non-Small Cell Lung Cancer Progressing On/After Checkpoint Inhibitor Therapy or Chemotherapy, Kai He, David Berz, Shirish M. Gadgeel, Wade T. Iams, Debora S. Bruno, Collin M. Blakely, Alexander I. Spira, Manish R. Patel, David M. Waterhouse, Donald A. Richards, Anthony Pham, Robert Jotte, David S. Hong, Edward B. Garon, Anne Traynor, Peter Olson, Lisa Latven, Xiaohong Yan, Ronald Shazer, and Ticiana A. Leal
Cancer is chronic but antimicrobial stewardship is iconic: A retrospective cohort of optimal antibiotic use in ambulatory oncology clinics, Tiffany A. Ho, Katelyn M. Patterson, Shirish M. Gadgeel, Rachel M. Kenney, and Michael P. Veve
A Bitter Taste Receptor as a Novel Molecular Target on Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma, Jessica Hung, Samantha M. Perez, Siva Sai Krishna Dasa, Sarah P. Hall, Danielle B. Heckert, Brian P. Murphy, Howard C. Crawford, Kimberly A. Kelly, and Lindsey T. Brinton
Biomarker-Directed Therapy in Black and White Men With Metastatic Castration-Resistant Prostate Cancer, Clara Hwang, Nicholas C. Henderson, Shih-Chun Chu, Brandon Holland, Frank C. Cackowski, Amanda B. Pilling, Albert Jang, Shoshana Rothstein, Matthew Labriola, Joseph J. Park, Alyssa Ghose, Mehmet A. Bilen, Seema Mustafa, Deepak Kilari, Michael J. Pierro, Bicky Thapa, Abhishek Tripathi, Rohan Garje, Aditya Ravindra, Vadim S. Koshkin, Erik Hernandez, Michael T. Schweizer, Andrew J. Armstrong, Rana R. McKay, Tanya B. Dorff, Ajjai S. Alva, and Pedro C. Barata
Brief Report on Use of Pembrolizumab With or Without Chemotherapy for Advanced Lung Cancer: A Real-World Analysis, Monika A. Izano, Connor Sweetnam, Chenan Zhang, James L. Weese, Douglas Reding, Jonathan Treisman, Anand Patel, Bindu Potugari, Andrew Stafford, Frank M. Wolf, Mary Tran, Thomas D. Brown, and Shirish M. Gadgeel
Tumor sequencing of African ancestry reveals differences in clinically relevant alterations across common cancers, Evelyn M. Jiagge, Dexter X Jin, Justin Y Newberg, Tomin Perea-Chamblee, Kelly R Pekala, Christopher Fong, Michele Waters, David Ma, Yvonne Dei-Adomakoh, Gilles Erb, Kanika S Arora, Sophia L Maund, Njoki Njiraini, Atara Ntekim, Susie Kim, Xuechun Bai, Marlene Thomas, Ronwyn van Eeden, Priti Hegde, Justin Jee, Debyani Chakravarty, Nikolaus Schultz, Michael F Berger, Garrett M Frampton, Ethan S Sokol, and Jian Carrot-Zhang
Impact of COVID-19 in patients on active melanoma therapy and with history of melanoma, Douglas B. Johnson, Michael B. Atkins, Cassandra Hennessy, Trisha Wise-Draper, Hannah Heilman, Joy Awosika, Ziad Bakouny, Chris Labaki, Renee Maria Saliby, Clara Hwang, Sunny R. K Singh, Nino Balanchivadze, Christopher R. Friese, Leslie A. Fecher, James J. Yoon, Brandon Hayes-Lattin, Mehmet A. Bilen, Cecilia A. Castellano, Gary H. Lyman, Lisa Tachiki, Sumit A. Shah, Michael J. Glover, Daniel B. Flora, Elizabeth Wulff-Burchfield, Anup Kasi, Saqib H. Abbasi, Dimitrios Farmakiotis, Kendra Viera, Elizabeth J. Klein, Lisa B. Weissman, Chinmay Jani, Matthew Puc, Catherine C. Fahey, Daniel Y. Reuben, Sanjay Mishra, Alicia Beeghly-Fadiel, Benjamin French, and Jeremy L. Warner
Targeting Cellular Metabolism With CPI-613 Sensitizes Pancreatic Cancer Cells to Radiation Therapy, Husain Yar Khan, Mandana Kamgar, Amro Aboukameel, Sahar Bannoura, Brian Y. Chung, Yiwei Li, Mohammed Najeeb Al Hallak, Philip A. Philip, Susan Tsai, Sanjeev Luther, William A. Hall, and Asfar S. Azmi
Race-Associated Genomic Correlates of Therapeutic Response in African American Patients With Non-Small-Cell Lung Cancer, Pin Li, Kaitlyn Kane, Frank M. Wolf, Anna B. Berry, Shirish M. Gadgeel, and Amanda B. Pilling
Powerful, scalable and resource-efficient meta-analysis of rare variant associations in large whole genome sequencing studies, Xihao Li, Corbin Quick, Hufeng Zhou, Sheila M Gaynor, Yaowu Liu, Han Chen, Margaret Sunitha Selvaraj, Ryan Sun, Rounak Dey, Donna K Arnett, Lawrence F Bielak, Joshua C Bis, John Blangero, Eric Boerwinkle, Donald W Bowden, Jennifer A Brody, Brian E Cade, Adolfo Correa, L Adrienne Cupples, Joanne E Curran, Paul S de Vries, Ravindranath Duggirala, Barry I Freedman, Harald H H Göring, Xiuqing Guo, Jeffrey Haessler, Rita R Kalyani, Charles Kooperberg, Brian G Kral, Leslie A Lange, Ani Manichaikul, Lisa W Martin, Stephen T McGarvey, Braxton D Mitchell, May E Montasser, Alanna C Morrison, Take Naseri, Jeffrey R O'Connell, Nicholette D Palmer, Patricia A Peyser, Bruce M Psaty, Laura M Raffield, Susan Redline, Alexander P Reiner, Muagututi'a Sefuiva Reupena, Kenneth M Rice, Stephen S Rich, Colleen M Sitlani, Jennifer A Smith, Kent D Taylor, Ramachandran S Vasan, Cristen J Willer, James G Wilson, Lisa R Yanek, Wei Zhao, Jerome I Rotter, Pradeep Natarajan, Gina M Peloso, Zilin Li, and Xihong Lin
KMT2D links TGF-β signaling to noncanonical activin pathway and regulates pancreatic cancer cell plasticity, Shuang Lu, Hong Sun Kim, Yubo Cao, Karan Bedi, Lili Zhao, Ishwarya Venkata Narayanan, Brian Magnuson, Yumei Gu, Jing Yang, Zhujun Yi, Sepideh Babaniamansour, Sargis Shameon, Chang Xu, Michelle T. Paulsen, Ping Qiu, Sivakumar Jeyarajan, Mats Ljungman, Dafydd Thomas, Yali Dou, Howard C. Crawford, Marina Pasca di Magliano, Kai Ge, Bo Yang, and Jiaqi Shi
Conformational plasticity of RAS Q61 family of neoepitopes results in distinct features for targeted recognition, Andrew C McShan, David Flores-Solis, Yi Sun, Samuel E Garfinkle, Jugmohit S. Toor, Michael C Young, and Nikolaos G Sgourakis
Arginase 1 is a key driver of immune suppression in pancreatic cancer, Rosa Elena Menjivar, Zeribe C. Nwosu, Wenting Du, Katelyn L. Donahue, Hanna S. Hong, Carlos Espinoza, Kristee Brown, Ashley Velez-Delgado, Wei Yan, Fatima Lima, Allison Bischoff, Padma Kadiyala, Daniel Salas-Escabillas, Howard C. Crawford, Filip Bednar, Eileen Carpenter, Yaqing Zhang, Christopher J. Halbrook, Costas A. Lyssiotis, and Marina Pasca di Magliano
COVID-19 severity and cardiovascular outcomes in SARS-CoV-2-infected patients with cancer and cardiovascular disease, Melissa Y. Y Moey, Cassandra Hennessy, Benjamin French, Jeremy L. Warner, Matthew D. Tucker, Daniel J. Hausrath, Dimpy P. Shah, Jeanne M. DeCara, Ziad Bakouny, Chris Labaki, Toni K. Choueiri, Susan Dent, Nausheen Akhter, Roohi Ismail-Khan, Lisa Tachiki, David Slosky, Tamar S. Polonsky, Joy A. Awosika, Audrey Crago, Trisha Wise-Draper, Nino Balanchivadze, Clara Hwang, Leslie A. Fecher, Cyndi Gonzalez Gomez, Brandon Hayes-Lattin, Michael J. Glover, Sumit A. Shah, Dharmesh Gopalakrishnan, Elizabeth A. Griffiths, Daniel H. Kwon, Vadim S. Koshkin, Sana Mahmood, Babar Bashir, Taylor Nonato, Pedram Razavi, Rana R. McKay, Gayathri Nagaraj, Eric Oligino, Matthew Puc, Polina Tregubenko, Elizabeth M. Wulff-Burchfield, Zhuoer Xie, Thorvardur R. Halfdanarson, Dimitrios Farmakiotis, Elizabeth J. Klein, Elizabeth V. Robilotti, Gregory J. Riely, Jean-Bernard Durand, Salim S. Hayek, Lavanya Kondapalli, Stephanie Berg, Timothy E. O'Connor, Mehmet A. Bilen, Cecilia Castellano, Melissa K. Accordino, Blau Sibel, Lisa B. Weissmann, Chinmay Jani, Daniel B. Flora, Lawrence Rudski, Miriam Santos Dutra, Bouganim Nathaniel, Erika Ruíz-García, Diana Vilar-Compte, Shilpa Gupta, Alicia Morgans, and Anju Nohria
Daclatasvir, an Antiviral Drug, Downregulates Tribbles 2 Pseudokinase and Resensitizes Enzalutamide-Resistant Prostate Cancer Cells, Jitender Monga, Frederick A. Valeriote, Clara Hwang, Shirish M. Gadgeel, and Jagadananda Ghosh
Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis, Guru Subramanian Guru Murthy, Soyoung Kim, Noel Estrada-Merly, Muhammad Bilal Abid, Mahmoud Aljurf, Amer Assal, Talha Badar, Sherif M. Badawy, Karen Ballen, Amer Beitinjaneh, Jan Cerny, Saurabh Chhabra, Zachariah DeFilipp, Bhagirathbhai Dholaria, Miguel Angel Diaz Perez, Shatha Farhan, Cesar O. Freytes, Robert Peter Gale, Siddhartha Ganguly, Vikas Gupta, Michael R. Grunwald, Nada Hamad, Gerhard C. Hildebrandt, Yoshihiro Inamoto, Tania Jain, Omer Jamy, Mark Juckett, Matt Kalaycio, Maxwell M. Krem, Hillard M. Lazarus, Mark Litzow, Reinhold Munker, Hemant S. Murthy, Sunita Nathan, Taiga Nishihori, Guillermo Ortí, Sagar S. Patel, Marjolein Van der Poel, David A. Rizzieri, Bipin N. Savani, Sachiko Seo, Melhem Solh, Leo F. Verdonck, Baldeep Wirk, Jean A. Yared, Ryotaro Nakamura, Betul Oran, Bart Scott, and Wael Saber
Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study, Gayathri Nagaraj, Shaveta Vinayak, Ali Raza Khaki, Tianyi Sun, Nicole M Kuderer, David M Aboulafia, Jared D Acoba, Joy Awosika, Ziad Bakouny, Nicole B Balmaceda, Ting Bao, Babar Bashir, Stephanie Berg, Mehmet A Bilen, Poorva Bindal, Sibel Blau, Brianne E Bodin, Hala T Borno, Cecilia Castellano, Horyun Choi, John Deeken, Aakash Desai, Natasha Edwin, Lawrence E Feldman, Daniel B Flora, Christopher R Friese, Matthew D Galsky, Cyndi J Gonzalez, Petros Grivas, Shilpa Gupta, Marcy Haynam, Hannah Heilman, Dawn L Hershman, Clara Hwang, Chinmay Jani, Sachin R Jhawar, Monika Joshi, Virginia Kaklamani, Elizabeth J Klein, Natalie Knox, Vadim S Koshkin, Amit A Kulkarni, Daniel H Kwon, Chris Labaki, Philip E Lammers, Kate I Lathrop, Mark A Lewis, Xuanyi Li, Gilbert de Lima Lopes, Gary H Lyman, Della F Makower, Abdul-Hai Mansoor, Merry-Jennifer Markham, Sandeep H Mashru, Rana R McKay, Ian Messing, Vasil Mico, Rajani Nadkarni, Swathi Namburi, Ryan H Nguyen, Taylor Kristian Nonato, Tracey Lynn O'Connor, Orestis A Panagiotou, Kyu Park, Jaymin M Patel, Kanishka GopikaBimal Patel, Jeffrey Peppercorn, Hyma Polimera, Matthew Puc, Yuan James Rao, Pedram Razavi, Sonya A Reid, Jonathan W Riess, Donna R Rivera, Mark Robson, Suzanne J Rose, Atlantis D Russ, Lidia Schapira, Pankil K Shah, M Kelly Shanahan, Lauren C Shapiro, Melissa Smits, Daniel G Stover, Mitrianna Streckfuss, Lisa Tachiki, Michael A Thompson, Sara M Tolaney, Lisa B Weissmann, Grace Wilson, Michael T Wotman, Elizabeth M Wulff-Burchfield, Sanjay Mishra, Benjamin French, Jeremy L Warner, Maryam B Lustberg, Melissa K Accordino, and Dimpy P Shah
Intracranial Efficacy of Adagrasib in Patients From the KRYSTAL-1 Trial With KRAS(G12C)-Mutated Non-Small-Cell Lung Cancer Who Have Untreated CNS Metastases, Marcelo V. Negrao, Alexander I. Spira, Rebecca S. Heist, Pasi A. Jänne, Jose M. Pacheco, Jared Weiss, Shirish M. Gadgeel, Karen Velastegui, Wenjing Yang, Hirak Der-Torossian, James G. Christensen, and Joshua K. Sabari
A phase I clinical trial of oncolytic adenovirus mediated suicide and interleukin-12 gene therapy in patients with recurrent localized prostate adenocarcinoma, Shyam Nyati, Hans Stricker, Kenneth N. Barton, Pin Li, Mohamed A. Elshaikh, Haythem Y. Ali, Stephen L. Brown, Clara Hwang, James O. Peabody, Svend O. Freytag, Benjamin Movsas, and Farzan Siddiqui
Ibrutinib combination therapy for advanced gastrointestinal and genitourinary tumours: results from a phase 1b/2 study, Do-Youn Oh, Maria Alsina Maqueda, David I. Quinn, Peter J. O'Dwyer, Ian Chau, Sun Young Kim, Ignacio Duran, Daniel Castellano, Jordan Berlin, Begona Mellado, Stephen K. Williamson, Keun-Wook Lee, Francisca Marti, Paul Mathew, Muhammad Wasif Saif, Ding Wang, Elizabeth Chong, Jacqueline Hilger-Rolfe, James P. Dean, and Hendrik-Tobias Arkenau
Aplastic Anemia Mimicking Myelofibrosis: A Diagnostic Dilemma, Neel Patel, Hamza Mirza, Payal Bai, Vedant Shah, Harsh Patel, Milan Khealani, Geetika Kukreja, and Sri J. Obulareddy
Tarlatamab, a First-In-Class DLL3-Targeted Bispecific T-Cell Engager, in Recurrent Small Cell Lung Cancer: An Open-Label, Phase I Study., Luis Paz-Ares, Stephane Champiat, W. Victoria Lai, Hiroki Izumi, Ramaswamy Govindan, Michael Boyer, Horst-Dieter Hummel, Hossein Borghaei, Melissa L. Johnson, Neeltje Steeghs, Fiona Blackhall, Afshin Dowlati, Noemi Reguart, Tatsuya Yoshida, Kai He, Shirish M. Gadgeel, Enriqueta Felip, Yiran Zhang, Amrita Pati, Mukul Minocha, Sujoy Mukherjee, Amanda Goldrick, Dirk Nagorsen, Nooshin Hashemi Sadraei, and Taofeek K. Owonikoko
Uncovering the Burden of Immune-Related Adverse Events in Immunotherapy: Insights from a Nationally Representative Sample, Rayli Pichardo, Yazan Abu Omar, Kashmira Wani, Kathren Shango, and Ding Wang
A Rare Case of Splenic Infarct Secondary to Mobile Cardiac Echodensity, Sruthi Ramanan, Harjinder Singh, Omair Ahmed, Mark Zande, and Malcolm Trimble
Short-term changes in ultrasound tomography measures of breast density and treatment-associated endocrine symptoms after tamoxifen therapy, Cody Ramin, Ruth M. Pfeiffer, Sharon Fan, Maeve Mullooly, Roni T. Falk, Kristine Jones, Neil E. Caporaso, Lisa Bey-Knight, Mark A. Sak, Michael S. Simon, David H. Gorski, Haythem Y. Ali, Peter Littrup, Neb Duric, Mark E. Sherman, and Gretchen L. Gierach
Stereoselective Synthesis of Sialyl Lewis(a) Antigen and the Effective Anticancer Activity of Its Bacteriophage Qβ Conjugate as an Anticancer Vaccine, Zahra Rashidijahanabad, Sherif Ramadan, Nicholas A O'Brien, Athar Nakisa, Shuyao Lang, Howard C. Crawford, Jeffrey C Gildersleeve, and Xuefei Huang
A Novel Role of Prostate-Specific Membrane Antigen in Telomere Stability in Prostate Cancer Cells, Vidyavathi Reddy, Clara Hwang, G. Prem-Veer Reddy, and Sahn-Ho Kim
PP01.10 A Randomized, Open-Label Phase 2 Study of the TORC 1/2 Inhibitor Sapanisertib in Relapsed/Refractory (R/R) NFE2L2 (NRF2)-Mutated and Wild-Type (WT) Squamous Non-Small Cell Lung Cancer (sqNSCLC), J. W. Riess, M. L. Johnson, Shirish M. Gadgeel, F. Skoulidis, B. Sumrow, E. Kuriakose, K. Albert, N. Kittrell, L. Akella, G. Fiji, and P. Paik
Pancreatic Ubap2 deletion regulates glucose tolerance, inflammation, and protection from cerulein-induced pancreatitis, Ram Vinod Roy, Nicolas Means, Geeta Rao, Sima Asfa, Venkateshwar Madka, Anindya Dey, Yushan Zhang, Monalisa Choudhury, Kar-Ming Fung, Danny N Dhanasekaran, Jacob E Friedman, Howard C. Crawford, Chinthalapally V Rao, Resham Bhattacharya, and Priyabrata Mukherjee
Emerging Biomarkers in Immune Oncology to Guide Lung Cancer Management, Houssein Safa, Fawzi Abu Rous, Neel Belani, Hossein Borghaei, Shirish M. Gadgeel, and Balazs Halmos
SOX17 Deficiency Mediates Pulmonary Hypertension: At the Crossroads of Sex, Metabolism, and Genetics, Shreya Sangam, Xutong Sun, Tae-Hwi Schwantes-An, Manivannan Yegambaram, Qing Lu, Yinan Shi, Todd Cook, Amanda Fisher, Andrea L. Frump, Anna Coleman, Yanan Sun, Shuxin Liang, Howard C. Crawford, Katie A. Lutz, Avinash D. Maun, Michael W. Pauciulo, Jason H. Karnes, Ketul R. Chaudhary, Duncan J. Stewart, Paul R. Langlais, Mohit Jain, Mona Alotaibi, Tim Lahm, Yan Jin, Haiwei Gu, Haiyang Tang, William C. Nichols, Stephen M. Black, and Ankit A. Desai
Long exposure to a mixture of endocrine disruptors prediposes the ventral prostate of rats to preneoplastic lesions, Thaina Cavalleri Sousa, Letícia Pereira de Souza, Maria Luiza Silva Ricardo, Andreia Yuri Yoshigae, Karianne Delalibera Hinokuma, Ana Beatriz Ratto Gorzoni, Ariana Musa de Aquino, Wellerson Rodrigo Scarano, Anthony César de Sousa Castillho, Maria Eduarda Almeida Tavares, Alice Santos Cruz Veras, Giovana Rampazzo Teixeira, Gisele Alborghetti Nai, and Leonardo de Oliveira Mendes
Neoadjuvant therapy for pancreatic cancer, Christoph Springfeld, Cristina R. Ferrone, Matthew H. G Katz, Philip A. Philip, Theodore S. Hong, Thilo Hackert, Markus W. Büchler, and John Neoptolemos
Molecular features and race-associated outcomes of SPOP-mutant metastatic castration-resistant prostate cancer, Andrew Stangl, Christopher Wilner, Pin Li, Lucas G. Maahs, Clara Hwang, and Amanda B. Pilling
